论文信息 - Safety, tolerability, and clinical activity of selinexor in combination with pembrolizumab in treatment of metastatic non–small cell lung cancer - 字舞流文

Safety, tolerability, and clinical activity of selinexor in combination with pembrolizumab in treatment of metastatic non–small cell lung cancer

F. Meric-Bernstam | F. Fossella | A. Naing | B. Stephen | G. Blumenschein | F. Mott | D. Karp | M. Altan | D. Milton | Yanyan Tian | Janet Tu | Bulent Yilmaz | J. Heymach